Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home About Us
In the News

May 9, 2012
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2012 Results

May 1, 2012
Bioniche Life Sciences Inc. Commercializing Two Products for Canine Cancer

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Board of Directors

Board Mandate and Governance Guidelines

The composition of the Board of Directors reflects the Company's intent to have a majority of non-management Directors.

All Directors have a competence that contributes to the development of operating plans put forward by the company's management.

Non-Management Members
of the Board of Directors

Management Members
of the Board of Directors

Graeme McRae,
Chairman, President & CEO, Bioniche Life Sciences

Director Biographies

Dr. Stan Alkemade
Dr. Stan Alkemade received his veterinary degree from the University of Melbourne, Australia. He returned to Canada in 1971 and ran a mixed veterinary practice in Seaforth, Ontario for ten years. He has lectured in the Animal Health Technology program at the Centralia College of Agricultural Technology. In 1986, he joined Vetrepharm Canada Inc. as Technical Director and was responsible for research and development, product registrations, corporate technical services and facilities design. He is currently the President of BioMedEx, a project management firm for the pharmaceutical industry.

Top

Dr. Armen Aprikian (Observer)
Dr. Aprikian is Head of the Division of Urology, Department of Surgery, McGill University & Interim Chief of the Department of Oncology, McGill University Health Centre. He earned his Medical Degree at the University of Sherbrooke(Sherbrooke, Quebec) Faculty of Medicine and joined the Urology Training Program there upon graduating. He completed his residency at the McGill University Urology Residency Program (Montreal, Quebec) before attending Memorial Sloan-Kettering Cancer Center in New York. Dr. Aprikian subsequently joined the Department of Urology at the Montreal General Hospital as an Attending Surgeon. He served various academic and clinical roles in the Departments of Surgery (Division of Urology) and Oncology before becoming Head of the Division of Urology, Department of Surgery at McGill University and Interim Chief of the McGill University Health Centre’s Department of Oncology. His research has primarily focused on prostate and bladder cancers. Dr. Aprikian’s awards and honours include the Everett C. Reid Award for Excellence in Teaching, which he received on three occasions, the American Society of Clinical Oncology Investigator award. He was also named the McGill University William Dawson Scholar. He has been an invited lecturer locally, nationally and internationally and has held a number of Visiting Professorships.

Top

Albert Beraldo
Mr. Beraldo is the President of Alveda Pharmaceuticals Inc., a privately –owned Canadian company that is a leading supplier of pharmaceuticals to the Canadian health care market. He formerly served as President & CEO of Bioniche Pharma Group Ltd. until 2005. He also served as Director of Bioniche Life Sciences Inc. from 1984 to 2005. Mr. Beraldo has a Bachelor of Commerce degree from the University of Windsor and has a Chartered Accountant designation from the Canadian Institute of Chartered Accountants. He worked in public accounting with Ernst and Whinney until he joined Vetrepharm as Financial Controller in 1983. Mr. Beraldo has held several positions within the group of companies which amalgamated to form Bioniche and played a major role in the formation of Bioniche Inc., one of the amalgamating companies.

Top

 

Rod Budd
Rod Budd was a partner in Ernst & Young for 25 years until his retirement in 2010. For the last eight years of his term, he was the Canadian firm’s life sciences practice leader and responsible for establishing Ernst & Young as the leading business advisor to life sciences companies. Mr. Budd graduated from Concordia University in 1974 with a Bachelor of Commerce in accounting and finance and obtained his CA in 1977 (in Quebec and Ontario). He has over 30 years of experience in public accounting, serving emerging and growth companies, with a focus on life sciences companies, from start-ups to large multinationals. Mr. Budd also serves on the Advisory Board of the Rosalind and Morris Goodman Cancer Centre of McGill University, advises a number of private companies, and, effective October 1, 2011, sits on the Board and chairs the Audit Committee of Immunotec Inc.

Top

Margaret Cunningham
Margaret Cunningham has a Ph.D. in marketing from Texas A&M University and an MBA from the University of Calgary. Dr. Cunningham is the Director of the School of Business, Associate Dean, and the R. A. Jodrey Chair in the Faculty of Management at Dalhousie University in Halifax, Nova Scotia. She is an award winning teacher and widely published author. She served as Associate Professor of Marketing at the School of Business at Queen’s University in Kingston, Ontario until late 2008. She had been a Professor in the School of Business at Queen’s since 1989.

Top

Dr. James Johnson
Dr. James Johnson has a doctorate in biochemistry in addition to his law degree, and is a partner at Johnson, Marcou & Isaacs. Previously Dr. Johnson was a partner of the law firm King & Spalding LLP based in Atlanta, Georgia. Prior to that, he was a partner of the law firm Kilpatrick Stockton. Dr. Johnson has extensive experience in chemical and biotechnology patent prosecution and licensing.

Top

Nick Photiades

Nick Photiades is currently a management and strategic planning consultant. In November, 2008, he retired after a long career with the Business Development Bank of Canada, where he was Senior Director, Life Sciences, Venture Capital Division. Mr. Photiades holds a Bachelor of Science degree in Physics from Concordia University and a Graduate Diploma in Management from McGill University. He has served as a director in several public and private high technology companies, mainly in the biotechnology area; he also served on the Board of Directors of the Chamber of Commerce of Metropolitan Montréal; and presently serves on the St. Mary’s Hospital Foundation Board.

Top

The Hon. Lyle Vanclief
The Honourable Lyle Vanclief is former Minister of Agricultre and Agri-Food in the Government of Canada who is currently employed as an Agricultural and Agri-Food Consultant. He served as a Member of Parliament for the Government of Canada from 1988 to 2004. Throughout his political career, Mr. Vanclief held several parliamentary appointments, his most recent as Minister of Agriculture and Agri-Food. Prior to serving in public office, Mr. Vanclief previously spent 25 years as an agricultural entrepreneur in his home community of Ameliasburg, Ontario (Prince Edward County). He graduated with a Bachelor of Science degree in Agriculture from the University of Guelph in 1966. Mr. Vanclief is an Independent Director who will have key responsibilities for governance matters.

Top

Board Committee Charters

Top

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy